Bullish
Victory Capital Management Inc. significantly increased its stake in Bristol Myers Squibb (BMY) by over 102% in Q4, acquiring an additional 4.14 milli...
Neutral
Vontobel Holding Ltd. significantly reduced its stake in Bristol Myers Squibb, selling 248,546 shares in the fourth quarter, though still retaining a ...
Neutral
Representative Mike Kelly of Pennsylvania sold Bristol-Myers Squibb (NYSE: BMY) stock worth between $16,002 and $65,000, with the transaction occurrin...
Neutral
Takeda Pharmaceutical announced that its AI-designed psoriasis pill, zasocitinib, significantly outperformed Bristol Myers Squibb's Sotyktu in a head-...
Bearish
Takeda's AI-designed oral psoriasis drug, zasocitinib, significantly outperformed Bristol Myers Squibb’s Sotyktu in a Phase 3 study, achieving complet...
Neutral
Takeda Pharmaceutical announced that its experimental AI-developed psoriasis pill, zasocitinib, demonstrated superior efficacy compared to Bristol Mye...
Neutral
Takeda's experimental autoimmune drug, zasocitinib, outperformed Bristol Myers Squibb's Sotyktu in a head-to-head study for psoriasis, demonstrating s...
Bristol-Myers Squibb (BMY) has received positive news regarding its pipeline, including a Priority Review for Camzyos in adolescent obstructive hypert...
Bullish
Motley Fool Asset Management LLC increased its stake in Bristol Myers Squibb Company by 30.4% in the fourth quarter, acquiring an additional 50,403 sh...
Neutral
BioNTech and Bristol Myers Squibb announced encouraging interim Phase 2 data from their ROSETTA Lung-02 clinical trial evaluating pumitamig plus chemo...
Neutral
Focus Partners Advisor Solutions LLC grew its holdings in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 88.0% in the fourth quarter, accord...
Bristol-Myers Squibb (BMY) stock closed down 3.00% on June 8, primarily due to concerns over generic competition impacting key drugs like Revlimid, Po...
Actress Mariska Hargitay has partnered with Bristol Myers Squibb (BMS) for an awareness campaign called "Investigating Myeloma," inspired by her fathe...
Actress Mariska Hargitay has teamed up with Bristol Myers Squibb to launch the "Investigating Myeloma" awareness campaign. Commemorating the 20th anni...
Bullish
Bristol Myers Squibb has initiated an awareness campaign called "Investigating Myeloma" in collaboration with actor Mariska Hargitay, whose father die...
Bullish
Mariska Hargitay has partnered with Bristol Myers Squibb (BMS) to launch "Investigating Myeloma," an awareness campaign dedicating to highlighting the...
Bullish
Mariska Hargitay is honoring her father, Mickey Hargitay, in a new Bristol Myers Squibb (BMS) awareness campaign called "Investigating Myeloma." Her f...
Neutral
PBU The Pension Fund of Early Childhood & Youth Educators acquired a new stake in Bristol Myers Squibb Company (NYSE:BMY – Free Report) during the fou...
Neutral
Capital International Investors trimmed its holdings in Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 35.2% in the fourth quarter, accordin...
Bullish
Bristol Myers Squibb and SystImmune have announced positive phase 3 results for izalontamab brengitecan (iza-bren), a bispecific antibody-drug conjuga...